(Q67221439)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14345318%20AND%20SRC:MED&resulttype=core&format=json

reason for deprecated rank

15 December 2019

title

Weitere experimentelle Untersuchungen �ber L-DOPA beim Parkinson-Syndrom und Reserpin-Parkinsonismus (German)

marking inconsistent with the registered/official identifier/name

1 reference

reason for deprecated rank

19 February 2024

ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14345318

19 February 2024

1 reference

parkinsonian syndrome

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14345318

19 February 2024

metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14345318

19 February 2024

clinical research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14345318

19 February 2024

author name string

W. BIRKMAYER

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14345318

19 February 2024

O. HORNYKIEWICZ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14345318

19 February 2024

language of work or name

German

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14345318

19 February 2024

publication date

1 December 1964

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14345318%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

15 December 2019

http://link.springer.com/content/pdf/10.1007/BF00341704.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00341704/fulltext.html

19 February 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF00341704

19 February 2024

1 reference

Archiv fur Psychiatrie und Nervenkrankheiten

19 February 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14345318%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14345318%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

367-381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14345318%20AND%20SRC:MED&resulttype=core&format=json

A BIOCHEMICAL GLIA ERROR IN THE PARKINSON DISEASE

15 December 2019

cites work

1 reference

12 December 2020

HEAT REGULATION IN POSTENCEPHALITIC PARKINSONISM

1 reference

12 December 2020

The occurrence, distribution and physiological role of catecholamines in the nervous system

1 reference

12 December 2020

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

1 reference

12 December 2020

The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice

1 reference

12 December 2020

EXPERIENCES WITH L-DOPA IN THE THERAPY OF PARKINSONISM

1 reference

12 December 2020

A NEW CONCEPT OF TEMPERATURE REGULATION BY AMINES IN THE HYPOTHALAMUS.

1 reference

12 December 2020

Dopamine metabolism in Parkinson's disease.

1 reference

12 December 2020

[On the effects of I-DOPA on motor disorders in Parkinson's syndrome. An electromyographic study.]

1 reference

12 December 2020

[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

1 reference

12 December 2020

[The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease.]

1 reference

12 December 2020

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

12 December 2020

[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]

1 reference

12 December 2020

Interaction of the effects of tyramine, amphetamine and reserprine in man

1 reference

12 December 2020

ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS.

1 reference

12 December 2020

[On the effects of L-dopa in man and their modification by reserpine, chlorpromazine, iproniazid and vitamin B6]

1 reference

12 December 2020

[Behavior of monoamine oxidase in the brain of man after therapy with monoamine oxidase inhibitors.]

1 reference

12 December 2020

NEW MEANS OF CONTROLLING EXTRAPYRAMIDAL MOTOR DISORDERS

1 reference

12 December 2020

Occurrence and distribution of dopamine in brain and other tissues.

1 reference

12 December 2020

Dihydroxyphenylalanine in extrapyramidal disease.

1 reference

12 December 2020

Excretion of dopamine in diseases of basal ganglia.

1 reference

12 December 2020

THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY

1 reference

12 December 2020

Pharmacological Reviews

14

11

490

A. Carlsson

1959

1 reference

19 February 2024

Identifiers

DOI

10.1007/BF00341704

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14345318%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference